Labsystems Diagnostics is the first company in the world to introduce fluorometric microplate based assay for phenylalanine for diagnosing phenylketonuria (PKU) in newborns. Its pioneered Newborn Screening products and systems are based on fluorescence and photometric detections. All the reagent kits can be used manually in modular systems or in fully automated and hands off systems.
Labsystems Diagnostics' Neonatal 17-OH-Progesterone FEIA test is a fluorometric enzyme immunoassay enabling the quantification of 17-hydroxyprogestrone steroid present in blood samples dried on filter paper. The test can be used for the screening of newborn for Congenital Adrenal Hyperplasia (CAH).